You are here
We conduct public consultations as part of our broader stakeholder engagement work, including on changes to regulatory requirements or practices, reviews of business processes, standards or guidelines, and TGA fees and charges.
Closed on 13 June 2013
Proposed standards for human blood and blood components, human tissues and human cellular therapy products
Closed on 2 February 2011